ACR Video Pearls: PsA

Meeting Coverage

Richard Warren explains the factors he considers and what his "go-to" treatment is

Greater improvements over apremilast and placebo through 24 weeks

December 5, 2023

Philip Mease, MD, says this new instrument could be reliable in clinical practice

November 28, 2023

Philip Mease, MD, discusses real-world data presented at the ACR annual meeting

November 21, 2023

Late-onset PsA tied to worse functionality and more structural damage

December 14, 2022

Alexis Ogdie-Beatty, MD, says we need to turn to other items in our treatment toolbox

December 7, 2022

Health-related quality-of-life scores showed improvements as early as week 4

November 30, 2022

Philip Mease, MD, discusses the DISCOVER-2 abstracts presented at the ACR annual meeting

November 23, 2022

November 2023

June 2024